Glass fragment, from the edge of a slide, not from the patient. Note that the fragment diffracts light, is crystalline in structure. And is it not affecting, nor harming the surrounding cells.
‘Nano Delivery Tube’ presumably delivering mRNA materials. What triggers the release?
Notice the vapor trail exiting to the right. Visible because the tube landed partially in higher pressure serum and a lower pressure air bubble.
Graphene Oxide is a two-dimensional (2D) material composed of carbon atoms. Its bi-dimensional nature causes unique interactions with blood proteins and biological membranes that can lead to unusual effects like blood clotting and immune cell activation, when combined with mRNA, lipid nanoparticles, and more.
Several independent studies conducted by doctors and scientists have confirmed that graphene oxide and derivatives, are in fact present in the Covid-19 inoculations and swabs. But the manufacturers, medicine regulators, and so-called fact-checkers have refuted these claims, most likely due to forced suppression of the known toxic effects on the body.
Dr. Andreas Noack is a German expert in graphene nano structures. He describes these nanoscale structures as “tiny razor blades”. Only one atom layer thick, they are relatively wide and long. Fortunately we have observed their consumption by white blood cells, known as lymphocytes, in people with intact immune systems, these structure do deteriorate over time in a healthy, immunities-intact body.
Graphene hydrogel or nano gel is a water-based three dimensional (3D) graphene hybrid that readily absorbs water and swells to large volumes. Graphene hydrogel nanoparticles are outstanding drug delivery systems, owing to their unique properties that combine the characteristics of high water content with a very small (nano) size. They combine well with drugs, and most importantly carry lipid nanoparticles in even distribution, while enhancing the action of LNP targeting ligands. Graphene hydrogel is also designed for high performance electromagnetic wave attenuation.
None of these structures have ever been observed by us before April of 2021. In some cases they appear to be hybrids of graphene, in other cases strictly biological, perhaps from sources that have hybridized them.
The characteristic common to all graphene structures observed in blood is that they consume red cells, perhaps for their iron content, and in production of hybrid structures of various types and purpose.
These can be the beginnings of red cell clots or amyloid clots. We have proven that EDTA chelation therapy breaks up these clots and helps remove them from the body.
